WO1995009692A1 - Agent tensio-actif, et produit cosmetique en emulsion et liposome le contenant - Google Patents
Agent tensio-actif, et produit cosmetique en emulsion et liposome le contenant Download PDFInfo
- Publication number
- WO1995009692A1 WO1995009692A1 PCT/JP1994/000874 JP9400874W WO9509692A1 WO 1995009692 A1 WO1995009692 A1 WO 1995009692A1 JP 9400874 W JP9400874 W JP 9400874W WO 9509692 A1 WO9509692 A1 WO 9509692A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- trehalose
- fatty acid
- acid ester
- group
- ester
- Prior art date
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 38
- 239000004094 surface-active agent Substances 0.000 title claims abstract description 33
- 239000002502 liposome Substances 0.000 title claims abstract description 19
- 239000000839 emulsion Substances 0.000 title claims abstract description 10
- 239000000194 fatty acid Substances 0.000 claims abstract description 89
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 65
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 65
- -1 trehalose ester Chemical class 0.000 claims abstract description 58
- 229920003169 water-soluble polymer Polymers 0.000 claims abstract description 13
- 239000012528 membrane Substances 0.000 claims abstract description 11
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 63
- 229930195729 fatty acid Natural products 0.000 claims description 63
- 239000002253 acid Substances 0.000 claims description 48
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 47
- 150000002148 esters Chemical class 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 239000006071 cream Substances 0.000 claims description 18
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 13
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- 229920002472 Starch Polymers 0.000 claims description 8
- 239000008107 starch Substances 0.000 claims description 8
- 235000019698 starch Nutrition 0.000 claims description 8
- 239000012459 cleaning agent Substances 0.000 claims description 7
- 235000015110 jellies Nutrition 0.000 claims description 7
- 239000008274 jelly Substances 0.000 claims description 7
- 229920006395 saturated elastomer Polymers 0.000 claims description 7
- 125000001424 substituent group Chemical group 0.000 claims description 6
- 125000002252 acyl group Chemical group 0.000 claims description 5
- 239000002884 skin cream Substances 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 239000003599 detergent Substances 0.000 claims description 4
- 230000001804 emulsifying effect Effects 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 2
- 102000009027 Albumins Human genes 0.000 claims description 2
- 108010088751 Albumins Proteins 0.000 claims description 2
- 241000416162 Astragalus gummifer Species 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 102000011632 Caseins Human genes 0.000 claims description 2
- 108010076119 Caseins Proteins 0.000 claims description 2
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- 229920000832 Cutin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000001856 Ethyl cellulose Substances 0.000 claims description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 229920000057 Mannan Polymers 0.000 claims description 2
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 2
- 229920001615 Tragacanth Polymers 0.000 claims description 2
- 229940072056 alginate Drugs 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 239000005018 casein Substances 0.000 claims description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 2
- 235000021240 caseins Nutrition 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- 229920001577 copolymer Polymers 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 2
- 229920001249 ethyl cellulose Polymers 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims description 2
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims description 2
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 2
- 235000010487 tragacanth Nutrition 0.000 claims description 2
- 239000000196 tragacanth Substances 0.000 claims description 2
- 229940116362 tragacanth Drugs 0.000 claims description 2
- 125000000647 trehalose group Chemical group 0.000 claims description 2
- 150000003625 trehaloses Chemical class 0.000 claims description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims 1
- 229920002907 Guar gum Polymers 0.000 claims 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 claims 1
- 235000010489 acacia gum Nutrition 0.000 claims 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims 1
- 235000010418 carrageenan Nutrition 0.000 claims 1
- 239000000679 carrageenan Substances 0.000 claims 1
- 229920001525 carrageenan Polymers 0.000 claims 1
- 229940113118 carrageenan Drugs 0.000 claims 1
- 235000010417 guar gum Nutrition 0.000 claims 1
- 239000000665 guar gum Substances 0.000 claims 1
- 229960002154 guar gum Drugs 0.000 claims 1
- 229940068984 polyvinyl alcohol Drugs 0.000 claims 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 claims 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 claims 1
- 150000004671 saturated fatty acids Chemical class 0.000 claims 1
- 239000001488 sodium phosphate Substances 0.000 claims 1
- 229910000162 sodium phosphate Inorganic materials 0.000 claims 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims 1
- 238000003860 storage Methods 0.000 abstract description 18
- 239000000126 substance Substances 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 2
- 230000002035 prolonged effect Effects 0.000 abstract 2
- 230000000638 stimulation Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 41
- 239000000203 mixture Substances 0.000 description 34
- 238000000034 method Methods 0.000 description 23
- 238000002360 preparation method Methods 0.000 description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 18
- 150000004665 fatty acids Chemical class 0.000 description 18
- 238000003756 stirring Methods 0.000 description 18
- 239000003921 oil Substances 0.000 description 14
- 235000019198 oils Nutrition 0.000 description 13
- 230000001953 sensory effect Effects 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 230000007774 longterm Effects 0.000 description 12
- 229930006000 Sucrose Natural products 0.000 description 11
- 239000005720 sucrose Substances 0.000 description 11
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 239000002245 particle Substances 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 206010040880 Skin irritation Diseases 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 9
- 231100000475 skin irritation Toxicity 0.000 description 9
- 230000036556 skin irritation Effects 0.000 description 9
- 239000007864 aqueous solution Substances 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- 235000013336 milk Nutrition 0.000 description 8
- 210000004080 milk Anatomy 0.000 description 8
- 235000010469 Glycine max Nutrition 0.000 description 7
- 238000004140 cleaning Methods 0.000 description 7
- 239000008267 milk Substances 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- 244000068988 Glycine max Species 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000006188 syrup Substances 0.000 description 6
- 235000020357 syrup Nutrition 0.000 description 6
- 239000010409 thin film Substances 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N butyl alcohol Substances CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000004006 olive oil Substances 0.000 description 5
- 235000008390 olive oil Nutrition 0.000 description 5
- 239000002304 perfume Substances 0.000 description 5
- 230000036548 skin texture Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000000527 sonication Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000002296 dynamic light scattering Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 239000002736 nonionic surfactant Substances 0.000 description 4
- 150000003904 phospholipids Chemical class 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000000700 radioactive tracer Substances 0.000 description 3
- 230000015227 regulation of liquid surface tension Effects 0.000 description 3
- 210000003705 ribosome Anatomy 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 239000013076 target substance Substances 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-Hydroxyoctadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000206575 Chondrus crispus Species 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 239000000232 Lipid Bilayer Substances 0.000 description 2
- HPEUJPJOZXNMSJ-UHFFFAOYSA-N Methyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC HPEUJPJOZXNMSJ-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 235000014443 Pyrus communis Nutrition 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 230000003625 amylolytic effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- XSIFPSYPOVKYCO-UHFFFAOYSA-N butyl benzoate Chemical compound CCCCOC(=O)C1=CC=CC=C1 XSIFPSYPOVKYCO-UHFFFAOYSA-N 0.000 description 2
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940099578 hydrogenated soybean lecithin Drugs 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- KDQIFKKWPMBNOH-UHFFFAOYSA-N methyl 16-methylheptadecanoate Chemical compound COC(=O)CCCCCCCCCCCCCCC(C)C KDQIFKKWPMBNOH-UHFFFAOYSA-N 0.000 description 2
- QSQLTHHMFHEFIY-UHFFFAOYSA-N methyl behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OC QSQLTHHMFHEFIY-UHFFFAOYSA-N 0.000 description 2
- YRHYCMZPEVDGFQ-UHFFFAOYSA-N methyl decanoate Chemical compound CCCCCCCCCC(=O)OC YRHYCMZPEVDGFQ-UHFFFAOYSA-N 0.000 description 2
- UQDUPQYQJKYHQI-UHFFFAOYSA-N methyl laurate Chemical compound CCCCCCCCCCCC(=O)OC UQDUPQYQJKYHQI-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229940105132 myristate Drugs 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011076 safety test Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- FNZSVEHJZREFPF-SSDOTTSWSA-N (2r)-2-pentylbutanedioic acid Chemical compound CCCCC[C@@H](C(O)=O)CC(O)=O FNZSVEHJZREFPF-SSDOTTSWSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- LHYJELNWFRVKCH-UHFFFAOYSA-N 1-(2-hydroxyphenyl)octadecan-1-one Chemical compound CCCCCCCCCCCCCCCCCC(=O)C1=CC=CC=C1O LHYJELNWFRVKCH-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241001481833 Coryphaena hippurus Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- KKUKTXOBAWVSHC-UHFFFAOYSA-N Dimethylphosphate Chemical compound COP(O)(=O)OC KKUKTXOBAWVSHC-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- JZTPOMIFAFKKSK-UHFFFAOYSA-N O-phosphonohydroxylamine Chemical compound NOP(O)(O)=O JZTPOMIFAFKKSK-UHFFFAOYSA-N 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- QBTBVZHWJLZAIC-UHFFFAOYSA-N P(=O)(O)(O)O.C(CCCCCCCCCC)(=O)O Chemical compound P(=O)(O)(O)O.C(CCCCCCCCCC)(=O)O QBTBVZHWJLZAIC-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 150000007860 aryl ester derivatives Chemical class 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- CAMHHLOGFDZBBG-UHFFFAOYSA-N epoxidized methyl oleate Natural products CCCCCCCCC1OC1CCCCCCCC(=O)OC CAMHHLOGFDZBBG-UHFFFAOYSA-N 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 125000005313 fatty acid group Chemical group 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003084 food emulsifier Nutrition 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N methyl monoether Natural products COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 150000004712 monophosphates Chemical class 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000010454 slate Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- C09K23/34—Higher-molecular-weight carboxylic acid esters
Definitions
- the present invention relates to a surfactant, an emulsified cosmetic containing the surfactant, and a ribosome.
- the present invention relates to a surfactant having excellent surfactant activity and excellent safety.
- the present invention also relates to a highly safe cleaning agent containing the surfactant.
- the present invention also relates to an emulsified cosmetic containing the above-mentioned surfactant, which is excellent in emulsion stability, skin safety and sensory characteristics.
- surfactants Conventionally, many compounds have been known as surfactants, and they have been used in various fields. However, some of these surfactants include shampoos, rinses, stone stones, cosmetics and other cosmetics that come into direct contact with the human body. Many indicate skin irritation. For this reason, the development of surfactants with lower irritation has been desired.
- emulsions include non-ionic surfactants having a polyoxyethylene chain, anionic surfactants such as fatty acids, cationic surfactants, or amphoteric surfactants. Agent is used.
- anionic surfactants such as fatty acids, cationic surfactants, or amphoteric surfactants.
- Agent is used.
- non-ionic surfactants which are said to be the least irritating, have many problems, such as poor skin familiarity, because many of them have polyoxyethylene chains. I did.
- alkyl esterified saccharides are nonionic surfactants widely used widely in foods, cosmetics and the like.
- sucrose alkyl esters using sucrose as a sugar skeleton are widely used, and there are many reports (JP-A-56-5553). No. 6). However, these do not have sufficient functional properties and long-term storage stability. It is also known to use trenulose-6,6'-dialkylester using a trehalose derivative as a sugar skeleton as a surfactant. (Japanese Unexamined Patent Publication No. 60-258,195, Japanese Unexamined Patent Publication No. Sho 62-91236). Their emulsifying ability is not sufficient.
- Trehalose-16,6'-difatty acid ester as an antitumor agent
- emulsifying type combined with a specific emulsifier composition
- An antitumor agent is known (Japanese Patent Application Laid-Open No. 61-28938).
- the alkyl group as the lipophilic group be a single one.
- a monoester of fatty acid monoester has been reported (Japanese Patent Application Laid-Open No. 3-157349), but has the disadvantage that the hydrophilicity is weak and a stable emulsion cannot be obtained. You. Disclosure of the invention
- An object of the present invention is to provide a surfactant excellent in surface activity and safety.
- Another object of the present invention is to provide a cleaning agent excellent in safety. Another object of the present invention is to provide an emulsified cosmetic having low skin irritation, excellent long-term storage stability, extremely excellent sensory properties, and fine and beautiful appearance. It is to provide.
- the present invention has the following general formula:
- R is a saturated or unsaturated acyl group having 8 to 22 carbon atoms, and may have a substituent, for example, an OH group.
- a surfactant containing one or more selected from the group consisting of trehalose-16-fatty acid esters is a surfactant containing one or more selected from the group consisting of trehalose-16-fatty acid esters.
- Another preferred embodiment of the present invention is a surfactant containing 61-laurenol-in-trenolose.
- Another preferred embodiment of the present invention is a surfactant containing 6-stearolene monotrehalose.
- R is a saturated or unsaturated acyl group having 8 to 22 carbon atoms, and may have a substituent, for example, an OH group.
- a cleaning agent characterized by containing a surfactant containing one or more of trehalose-6-fatty acid esters represented by.
- R is a saturated or unsaturated acyl group having 8 to 22 carbon atoms, and may have a substituent, for example, a 0H group.
- An emulsified cosmetic comprising one or more selected from the group consisting of trehalose-6-fatty acid esters and a water-soluble polymer.
- the trehalose-16-fatty acid ester of the present invention can be obtained by a condensation reaction of trehalose with a fatty acid or an ester exchange reaction with a fatty acid ester. .
- Fatty acids or fatty acid esters that can be used in the present invention include synthetic fatty acids and their esters, naturally occurring fatty acids such as soybean fatty acids, beef tallow, cottonseed fat, olive oil, Pear oils and the like and fatty acid esters obtained by lowering them by a usual method can be mentioned.
- Trehalose that can be used in the present invention includes ⁇ , ⁇ -tismelose, a,; 3—trehalose, ⁇ , / S—trehalose. Any of these may be used, or a mixture of two or more of them may be used.
- the trehalose-6-fatty acid ester of the present invention can be obtained by using a conventional method for producing a sucrose alkyl ester.
- a conventional method for producing a sucrose alkyl ester for example, U.S. Pat. No. 2,893,990, U.S. Pat. No. 3,936,699, Japanese Patent Application Laid-Open No. 36-21710, Japanese Patent Application — It can be obtained by the method described in Japanese Patent Application Publication No. 6130, and these specifications and publications are incorporated herein by reference.
- Trehalose-16-fatty acid ester can be obtained as a main reaction product.
- unreacted Trehalose ⁇ a small amount of Trehalose — 6, 6 '— fatty acid ester as a byproduct is present in the reaction mixture.
- Trehalose-6-fatty acid The ester may be used after purification, but it may be used in the presence of a small amount of unreacted trenolose or a mixture of trenopene soot-6,6′-fatty acid diester.
- Trehalose — 6 — Fatty acid esters may be included because they exhibit surface-active properties.
- the trehalose-16-fatty acid ester used in the present invention is a saturated or straight-chain or branched-chain alkyl having 822 carbon atoms as the fatty acid residue. Those having an alkyl group or an alkenyl group are preferred.
- the surfactants of the present invention include 6- (10-didecylenyl) -trehalose, 6-laurolitol phenolic cellulose, 6-stearoyl phenol. Surfactants consisting of one or more than one of the transyloses are preferred.
- the surfactant of the present invention has excellent surfactant activity and skin safety, and can be used as a food emulsifier.
- the skin or hair cleansing agent of the present invention may contain one or more of the above-mentioned trehalose 16-fatty acid esters, preferably in an amount of 1 to 50% by weight, more preferably 1035% by weight. Include in quantity. Other surfactants may be included.
- the cosmetic of the present invention is a kind of the above-mentioned trehalose-16-fatty acid ester. Contains two or more and a water-soluble polymer.
- the content of the above-mentioned trehalose-16-fatty acid ester in the cosmetic is preferably from 0.01 to 20% by weight, based on the total amount of the cosmetic, and from 0.1 to 20% by weight. ⁇ 10% by weight is even more preferred. If the amount is less than 0.01% by weight, the emulsion stability during storage of the cosmetic tends to decrease, and if the amount is more than 20% by weight, a good feeling when using the cosmetic is obtained. It will be difficult to do so.
- the water-soluble polymer used in the cosmetic of the present invention may be any of the water-soluble polymers used in cosmetics and pharmaceutical bases.
- lenene oxide propylene copolymer cationized
- the content of the water-soluble polymer in the cosmetic of the present invention is preferably 0.01 to 40% by weight, and 0.01 to 20% by weight based on the total amount of the cosmetic. % Is even more preferred. If the amount is less than 0.01% by weight, the emulsification stability during storage of the cosmetic tends to decrease, while if it is more than 40% by weight, the Good feel is difficult to obtain.
- the cosmetic of the present invention may contain, if necessary, one or a combination of two or more oily substances that can be used for cosmetics and pharmaceutical bases.
- oily substances such as raffin, squalane, petrolatum, microcriss, and wax
- rouxes such as migrant, whale and dolphin
- Vegetable oils such as oil, jojoba oil
- animal oils such as turtle oil, mink oil, egg yolk oil
- Higher fatty acids such as arnic acid, oleic acid, linoleic acid, linolenic acid, ricinoleic acid and isostearic acid; dimethylsilicone Silicone oils such as silicones, methylvinyl alcohol, and cyclic silicones; and other silicone resins and polymer silicones. be able to .
- the cosmetic of the present invention may contain a polyhydric alcohol such as ethylene glycol, propylene glycol, and 1,3-butyl alcohol.
- a polyhydric alcohol such as ethylene glycol, propylene glycol, and 1,3-butyl alcohol.
- the cosmetic composition of the present invention includes a moisturizing agent, a cosmetic active ingredient, a fragrance, a preservative, a coloring agent, an ultraviolet absorber, an astringent, a synthetic surfactant, a pigment (power oil, my power, cellulase). , Talc, iron oxide yellow, iron oxide red, titanium oxide, etc.), water, etc., which are commonly used in cosmetics and pharmaceutical bases.
- the cosmetic of the present invention may be used for a massage cream, a cleaning cream, a skin cream, a foundation cream, a makeup cream. Includes, but is not limited to, app base, hair cream, massage jelly, medicated jelly, and the like.
- the present invention will be described in detail with reference to Examples, but the present invention is not limited to the following Examples.
- Example 16 Preparation of 16- (10-dendirenyl) -trehalose a) a, ⁇ -Troleose 100 g of 400 ml of dimethyl alcohol Dissolved in amide. To this solution was added 52.4 g of 10-methyl didecylate and 1.O g of potassium hydroxide, and the temperature was raised to 100. Stirred for hours. After cooling the reaction solution, it was extracted three times with 400 ml of hexane to remove unreacted methyl 10-didecylate. The dimethylformamide solution containing the target substance is concentrated under reduced pressure to about 200 ml, and then 100 ml of acetate is added thereto. The loose was settled and removed by filtration.
- the precipitate was washed with 100 ml of n-butanol, and the washing solution was added to the filtrate and mixed.
- the filtrate was distilled under reduced pressure to obtain a pale yellow viscous syrup.
- ⁇ -Traceose 100 g was dissolved in 400 ml of dimethisolev onolem amide. To this solution were added 60 g of soybean fatty acid methyl and 1.0 Og of a hydrating power, heated to 100 ° C., and stirred for 18 hours. After the reaction solution was cooled, unreacted soybean fatty acid methyl was removed by extracting it five times with 400 ml of hexane. The dimethylformamide solution containing the target substance is concentrated under reduced pressure to about 200 ml, then 150 ml of acetone is added, and the unreacted trehalose is added. The precipitate was removed by filtration.
- 6-Rauro as a pale yellow viscous syrup in the same manner as in Example 4 except that 60 g of methyl oyster fatty acid was used instead of 60 g of soy fatty acid methyl. There were obtained 34.9 g of trerose-16-oil oil fatty acid ester mainly composed of root rehalose. Safety test
- a liquid skin cleanser having the composition shown in Table 2 below was prepared using the steal. As a result of washing the face with these leather cleaning agents, the dirt was cleanly removed and the feel was good.
- Example 1 Example 12
- Example 13 Component% by weight% by weight% by weight
- the sample composition was left in a thermostat at 45 for 1 to 6 months, and then the appearance was visually evaluated.
- Trehalose-1 6- Fatty acid ester is used as a fatty acid ester, using the above-mentioned 6- Lauroyl trehalose as a skin formula with the formulation shown in Table 5 below.
- Milk was prepared. Components 1 to 5 in Table 5 were uniformly mixed and dissolved at about 80 ° C (solution 1). The components 6 to 10 and 12 in the table were uniformly mixed and dissolved at about 80 ° C. (solution 2). Next, while stirring the above solution 2 with a homomixer, the solution 1 was added and emulsified, and then cooled to room temperature with stirring. During the cooling, when the temperature reached 70 ° C., component 11 was added, and the temperature was further lowered to room temperature, and then stirring was stopped.
- Table 5 shows the properties of the resulting skin milk.
- the skin milks of Examples 14 to 17 have excellent long-term storage stability, sensory characteristics and appearance characteristics, and have skin irritation. There was no one. Comparative Examples 1-3 Preparation of skin milk
- Skin milk was prepared using the formulations shown in Table 6 in the same manner as in Examples 14 to 17.
- Table 6 shows the properties of the resulting skin milk.
- Components 1 to 6 in Table 7 were uniformly mixed and dissolved at about 80 ° C (solution 1). Also, the ingredients in the table? -9 and 11 were uniformly mixed and dissolved at about 80 ° C (solution 2).
- the solution 1 was added and emulsified while stirring the solution 2 with a homogenizer, and then cooled to room temperature with stirring. During the cooling, when the temperature reached 70 ° C., component 10 was added, and after the temperature was further lowered to room temperature, the stirring was stopped.
- Table 7 shows the characteristics of the obtained skin stream.
- a make-up base was prepared according to the following formulation.
- the monoisostearic acid trehalose used was synthesized from trehalose and methyl isostearate in the same manner as in Example 1.
- the oily components 1 to 6 in the above components were mixed and dissolved at about 80 ° C. (solution 1).
- the aqueous components 7 to 10 and 14 were mixed and melted at about 80 ° C. (solution 2).
- the component 12 was dispersed in the component 11 (dispersion liquid).
- stirring the solution 2 with a homomixer adding the solution 1 and emulsifying the mixture. Cooled. During the cooling, when the temperature reached 70 ° C., component 13 was added, and after the temperature was further lowered to room temperature, the stirring was stopped.
- the makeup base obtained in this way was an oil-in-water emulsion emulsion, which was stored for 4 months in a 45 ° C constant temperature bath. Even later, the stability was extremely good. Furthermore, the organoleptic properties (skin familiarity and firmness) were good, and the appearance (skin texture) was also good.
- Example 22 2 Preparation of hair cream
- Hair cream was prepared according to the following formulation.
- the used monobehenic acid trehalose was synthesized from trehalose and methyl behenate in the same manner as in Example 1.
- the oily component 17 in the above components was mixed and dissolved at about 80 ° C (solution 1).
- the aqueous components 814 and 16 were mixed and melted at about 80 ° C. (solution 2).
- the solution 1 was added and emulsified while stirring the solution 2 with a homomixer, and the mixture was cooled to room temperature while stirring. During the cooling, when the temperature reached 70 ° C., component 15 was added, and after the temperature was further lowered to room temperature, the stirring was stopped.
- the hair cream obtained in this way was extremely stable even after being stored for 6 months in a thermostat at 45 ° C. Furthermore, the organoleptic properties (skin familiarity and firmness) were good, and the appearance (skin texture) was also good.
- Example 2 3 Preparation of cleaning cream
- a cleaning cream was prepared according to the following formulation.
- the monolinolenic acid trehalose and monolinoleic acid traces used were prepared in the same manner as in Example 1 except for the use of trelinose and linolenic acid. It was synthesized from methyl or methyl caprate. Prescription:
- aqueous components 9 to 15 were mixed and melted at about 80 ° C. (solution 2).
- solution 2 was added and emulsified while stirring the solution 2 with a homogenizer, and the mixture was cooled to room temperature while stirring, and then the stirring was stopped.
- the cleaning cream obtained in this way has very good stability even after being stored in a thermostat at 45 ° C for 6 power months. Was. Furthermore, the sensory characteristics (skin familiarity and firmness) were good, and the appearance (skin texture) was also good.
- Example 2 Preparation of 4 mass jelly
- the mass jelly obtained in this way has extremely good stability even after being stored for 6 months in a thermostat at 45 ° C. Was. Furthermore, the organoleptic properties (skin familiarity, firmness) were good, and the appearance (skin texture) was also good.
- Example 2 Preparation of 5 cleaning gels
- a cleaning gel was prepared according to the following formulation.
- the used monohistoric acid trehalose was treated in the same manner as in Example 1 to obtain trehalose and trehalose. It was synthesized from methyl stinate.
- the oily components 1 to 4 in the above components were mixed and dissolved at about 80 ° C. (solution 1).
- the aqueous components 5 to 10 were mixed and melted at about 80 ° C. (solution 2).
- the solution 1 was added while stirring the solution 2 with a homomixer, and the temperature was lowered to room temperature. Then, the stirring was stopped.
- the cleaning gel obtained in this way has extremely good stability even after being stored for 6 months in a thermostat at 45 ° C. Was. Furthermore, the sensory characteristics (skin familiarity, firmness) were good, and the appearance (skin texture) was also good.
- the present invention also has a wall membrane formed of a fatty acid ester of trehalose, which can be applied to pharmaceuticals, quasi-drugs, cosmetics, and the like. It is about the featured revo-somme.
- Liposomes are closed vesicles whose membrane wall consists of a lipid bilayer. It is said that a natural biological membrane has a lipid bilayer structure, and this ribosome has a structure similar to a biological membrane. For this reason, ribosome has a high affinity for cell membranes and is expected to have a high potential as a drag carrier. In recent years, the development of ribosome preparations aimed at the drug delivery system has been expected not only in the pharmaceutical field but also in the pharmaceutical field.
- phospholipid lecithin
- phospholipid lecithin
- phospholipid-forming agent has excellent safety but lacks chemical and physical stability. Therefore, it is difficult to use them for practical use. That is, when ribosomes are prepared using phospholipids, chemical changes such as discoloration and generation of offensive odor occur due to long-term storage. Furthermore, physical changes such as aggregation and precipitation occur due to long-term storage and rehydration after freeze-drying. Due to these problems, the practical use of liposomes using phospholipids has not been achieved.
- dialkyl cation surfactants such as dialkyldimethylammonium chloride (Kunitake et al., J. Am. Chem. Soc., Vol. 99, p. 860) , 1977
- ⁇ -based nonionic surfactants such as polyoxyethylene-hardened castor oil (Japanese Patent Application Laid-Open No. 52-63775, Japanese Patent Application Laid-Open No. 59-59) No. 165 3 4) has been reported.
- sucrose fatty acid esters using saccharides as hydrophilic groups Japanese Patent Application Laid-open No. 61-207324
- glycose fatty acid esters Japanese Patent Application Laid-Open JP-A-2004-0820
- Glucose Alkyl Ether JP-A-59-106424
- the stability of these revo-somes is not sufficient.
- a method of adding saccharides such as trehalose to ribosome Japanese Patent Application Laid-Open No. 62-50
- No. 0102 publication and Tokuyo Sho 62-501631 publication have been reported.
- No examples have been reported yet that use trehalose fatty acid ester as a liposome-forming agent.
- the present invention is a ribosome characterized by having a membrane wall composed of fatty acid ester of trehalose.
- the present invention is also a ribosome characterized in that it has a membrane wall made of Treha monoester difatty acid ester.
- the present invention will be described in detail.
- the trenulose fatty acid ester used in the present invention may be prepared from tretulose and a fatty acid or a ester thereof by a known synthesis method, for example, by mixing trenulose and a fatty acid. It can be obtained by ester exchange reaction of lower alkyl ester.
- the trace may be any of a, ⁇ -trace, ⁇ , / 8_ trace, ⁇ , 3-trehalose, or any of them. A mixture of two or more of these may be used.
- reaction products a mixture of mono- and di-fatty acid esters of trehalose and tri- or higher fatty acids can be obtained as reaction products.
- Each of these can be isolated by a conventional purification method. However, they may be used as a mixture without isolation.
- trehalose polyfatty acid ester is preferable, and a diastereomer is particularly preferable.
- the fatty acids constituting the trehalose fatty acid ester are preferably those having 82 22 carbon atoms, and more preferably saturated or unsaturated higher fatty acids having 10 to 18 carbon atoms. .
- a polypuric acid trace a nonic acid trehalose, a chromic acid trace, a perdecanoic acid trace, Trehalose acid, tracer myristate, tracer panoremitic acid, tracer stearate, Trehalo arachinate , Behenic acid trehalose, decylenoic acid trehalose, oleic acid trehalose, linoleic acid treous, linoleic acid Lenoate trace, Isosteate phosphate, Hydroxysteate trace, Lisinoleate Trehalose Courses, etc.
- the fatty acids constituting the trehalose fatty acid ester may be a single fatty acid or a mixture of two or more fatty acids. It is not always necessary that the ester form has a high purity, but it is preferable that the content of the ester form is 30% by weight or more with respect to all the trehalose fatty acid esters.
- the ribosome of the present invention has an unremovable ribosome within a range that does not affect the ribosome formation ability.
- Trehalose and fatty acid esters may be included as reaction raw materials.
- the liposome of the present invention may consist of only a single type of trehalose fatty acid ester, or may consist of a mixture of two or more types.
- the ribosome of the present invention uses sterols such as cholesterol and cholesterol as a membrane stabilizer, and dicetylphosphorus as a charged substance.
- Antioxidants such as phosphate, phosphatidic acid, ganglioside, stearylamine, etc. may contain ⁇ -tocopherol as an antioxidant. No. The mixing ratio of these is not limited, but about 0.01 to about 2.0 parts by weight is added to 1 part by weight of trehalose fatty acid ester. Is preferred.
- a general method for preparing ribosome can be applied.
- portexing method, sonication method, preciprocal method, ethanol injection method, french press method, ether injection method , An annealing method, a WZOZW emulsion method, a reversed-phase evaporation method, and the like Any of these preparation methods may be used, and these preparation methods may be arbitrarily combined, but the present invention is not limited to these methods.
- a preparation method using the portex swing method and the sonication method will be described.
- the organic solvent is distilled off to obtain the trehalose fatty acid.
- a thin film consisting of an ester is formed.
- a buffer solution in which water-soluble components are dissolved is added, and the mixture is shaken with a vortex mixer or the like at a temperature not lower than the phase transition temperature to remove the thin film. .
- a multi-layer liposome is formed.
- sonication sonication
- SAV single-layer ribosome
- the ribosome of the present invention may contain generally used components of a pharmaceutical preparation, for example, a water-soluble polymer, a polyhydric alcohol, a preservative, and a chelating agent.
- torenolose dilaurate ester 100 mg was placed in a 50 ml Nas-type flask, and further added with 5 ml of a mouth opening foam and dissolved. .
- the flask was set in a mouthpiece and the solvent was slowly evaporated to remove the solvent.
- a thin film of trenolose dilaurate ester was formed on the inner wall of the sample.
- the inside was evacuated with a vacuum pump and dried for 3 hours. 4 ml of distilled water was added thereto, and the mixture was shaken while heating to 60 ° C, and the thin film was peeled off. At this point, it becomes a cloudy aqueous solution.
- a ribosome was prepared in the same manner as in Example A, except that an aqueous solution of carboxyfluorescein (CF) 100 mM was used instead of distilled water.
- CF carboxyfluorescein
- the ribosome solution was subjected to gel filtration, and the external phase (liposomal solution) was filtered. (Not in the system.) CF was removed. Thereafter, a Triton X —100 aqueous solution was added to destroy the ribosome. By measuring the fluorescence intensity before and after the addition of the Triton X-1000 aqueous solution, it was confirmed that CF was trapped in the internal phase (in the liposome). Was. The retention efficiency was 15.5%.
- Example 5 A liposome was prepared in the same manner as in Example A, except that the trenulose dilaurate ester was replaced with a trenopenose dipalmitate ester. Was produced. Electron microscope observation confirmed that MLV and SUV had been formed.
- Treloose monostearate ester 20 mg, Treloose distearate ester 6 Omg, Trehalose stealine over tris A mixture consisting of 2 mg of acid ester was added to 8 ml of ethanol, and dissolved by heating at 50 ° C. This solution was injected under pressure into a distilled water heated to 60 ° C using a syringe. As a result, a translucent aqueous solution was obtained. When this was observed in an electron microscope in the same manner as in Example A, SUV was confirmed.
- Trehalose mono-miristate ester 0.2 g, Trehalose distearate ester 0.6 g, Tri-oren treester A mixture consisting of 0.2 g of an aryl ester was added to 10 ml of ethanol, and the mixture was heated and dissolved at 50 ° C. This solution was injected under pressure using a syringe into distilled water heated to 60 ° C to prepare SUV. The particle diameter measured by the dynamic light scattering method was 73 nm.
- SUV was prepared in the same manner as in Example E, except that hydrogenated soybean lecithin was used in place of the toluene-diprose didecylate ester.
- the particle diameter was measured by the dynamic light scattering method and found to be 59 nm.
- An SUV was prepared in the same manner as in Example E except that sucrose didecylester was used in place of the trehalose didecylester. did.
- the particle diameter measured by the dynamic light scattering method was 70 nm.
- each ribosome was freeze-dried and the particle size after rehydration was examined.
- Table B shows the results.
- Table A 40 ° C, 3 months After storage
- Examples E and F were better than Comparative Example B. This is because the molecular structure of Trehalose didecylenoic acid is superior to that of sucrose didecylenoic acid in its symmetry. This is thought to contribute to the stability of the system.
- the ribosome of the present invention has excellent stability. Further, the liposome of the present invention can appropriately contain a water-soluble or oil-soluble drug, and can be used during the storage period. No chemical or physical change of the ribosome occurs. Therefore, the liposome of the present invention is useful in the fields of medicine, quasi-drugs, cosmetics, and the like, and can be used for injections, liquids for internal use, external preparations, lotions, emulsions, and creams. It is intended to provide a liposome preparation suitable for a serum, a serum, a hair restorer, and the like.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/628,674 US6497898B1 (en) | 1993-10-07 | 1994-05-31 | Surfactant, and an emulsion-type cosmetic composition and a lipsome containing said surfactant |
DE69431163T DE69431163T2 (de) | 1993-10-07 | 1994-05-31 | Liposom umfassend eine aus einem trehalosefettsäureester aufgebaute membranwand |
EP95904334A EP0729781B1 (en) | 1993-10-07 | 1994-05-31 | Liposome comprising a membrane wall composed of a trehalose fatty acid ester |
US11/716,599 US20070292462A1 (en) | 1993-10-07 | 2007-03-12 | Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant |
US11/716,870 US20070160556A1 (en) | 1993-10-07 | 2007-03-12 | Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant |
US12/325,646 US20090098172A1 (en) | 1993-10-07 | 2008-12-01 | Surfactant, and emulsion cosmetic and liposome each containing the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5/277653 | 1993-10-07 | ||
JP27765393A JP3187622B2 (ja) | 1993-10-07 | 1993-10-07 | リポソーム |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/246,431 Division US20040022819A1 (en) | 1993-10-07 | 2002-09-18 | Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant |
US10/246,431 Continuation US20040022819A1 (en) | 1993-10-07 | 2002-09-18 | Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1995009692A1 true WO1995009692A1 (fr) | 1995-04-13 |
Family
ID=17586431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1994/000874 WO1995009692A1 (fr) | 1993-10-07 | 1994-05-31 | Agent tensio-actif, et produit cosmetique en emulsion et liposome le contenant |
Country Status (5)
Country | Link |
---|---|
US (5) | US6497898B1 (ja) |
EP (1) | EP0729781B1 (ja) |
JP (1) | JP3187622B2 (ja) |
DE (1) | DE69431163T2 (ja) |
WO (1) | WO1995009692A1 (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040067212A1 (en) * | 1998-03-11 | 2004-04-08 | Kabushiki Kaisha Soken | Skin conditioner |
US6710038B1 (en) | 1999-12-14 | 2004-03-23 | Kibun Food Chemifa Co., Ltd. | Emulsification method using propylene glycol hyaluronate |
US20040180031A1 (en) * | 2002-03-07 | 2004-09-16 | Kabushiki Kaisha Soken | Skin conditioner |
TW200413018A (en) * | 2002-12-26 | 2004-08-01 | Shiseido Co Ltd | Oil-in-water type emulsified cosmetic |
WO2007063902A1 (ja) * | 2005-11-30 | 2007-06-07 | The Nisshin Oillio Group, Ltd. | トレハロース脂肪酸エステル組成物 |
CN101687167B (zh) * | 2007-07-02 | 2012-10-03 | 日清奥利友集团株式会社 | W/o/w型乳化组合物 |
FR2921253B1 (fr) * | 2007-09-26 | 2012-11-16 | Lvmh Rech | Composition cosmetique sous la forme d'une emulsion comprenant une phase aqueuse continue et une phase grasse dispersee et son procede de preparation |
US20130310467A1 (en) * | 2012-03-06 | 2013-11-21 | The Nisshin Oillio Group, Ltd. | Trehalose fatty acid ester composition |
PT2939025T (pt) * | 2012-12-28 | 2018-07-31 | Cellestis Ltd | Ensaio de resposta imune mediada por célula |
KR101648958B1 (ko) * | 2015-01-21 | 2016-08-17 | 김형준 | 모자 및 이에 장착된 연결구 |
KR101734981B1 (ko) * | 2015-08-28 | 2017-05-24 | (주)피앤지코퍼레이션 | 문자 또는 로고를 탈부착할 수 있는 장치 |
US11717578B2 (en) | 2017-08-09 | 2023-08-08 | University Of Cincinnati | Undecylenic acid-based nanocarriers for targeted drug delivery |
WO2023089562A1 (en) * | 2021-11-19 | 2023-05-25 | Greentech Global Pte. Ltd. | Water insoluble, high melting point saccharide fatty acid esters (sfae) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05137994A (ja) * | 1991-11-19 | 1993-06-01 | Kanebo Ltd | 界面活性剤 |
JPH05168893A (ja) * | 1991-12-19 | 1993-07-02 | Kanebo Ltd | 界面活性剤 |
JPH0616688A (ja) * | 1992-06-30 | 1994-01-25 | Nippon Oil & Fats Co Ltd | 脂肪酸糖エステル |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL111638C (ja) | 1955-12-12 | |||
US2893900A (en) * | 1956-01-09 | 1959-07-07 | Eugene S Machlin | Process of condensing polytetrafluoroethylene vapors onto a substrate and sintering the condensate |
DE1643795A1 (de) * | 1967-08-04 | 1971-07-01 | Cassella Farbwerke Mainkur Ag | Verfahren zur Herstellung von Zuckerestern |
DE1792410B2 (de) * | 1967-09-01 | 1980-03-13 | Apoteksvarucentralen Vitrum Apotekareaktiebolaget, Stockholm | Arzneimittelzubereitung zur intravenösen Injektion |
FR2001118A1 (ja) * | 1968-02-01 | 1969-09-26 | Kyowa Hakko Kogyo Kk | |
US3558667A (en) * | 1968-11-01 | 1971-01-26 | Sterling Drug Inc | Benzofurans from o-phenyl ketoximes |
GB1399927A (en) * | 1971-09-11 | 1975-07-02 | Dai Ichi Kogyo Seiyaku Co Ltd | Detergent compositions |
US3963699A (en) | 1974-01-10 | 1976-06-15 | The Procter & Gamble Company | Synthesis of higher polyol fatty acid polyesters |
FR2315991A1 (fr) | 1975-06-30 | 1977-01-28 | Oreal | Procede de fabrication de dispersions aqueuses de spherules lipidiques et nouvelles compositions correspondantes |
JPS536130A (en) | 1976-07-05 | 1978-01-20 | Hitachi Seiko Kk | Device for detecting location of paper |
JPS5525430A (en) * | 1978-08-10 | 1980-02-23 | Nippon Saafuakutanto Kogyo Kk | Thickening and gelling agent |
GB2065102B (en) * | 1979-04-05 | 1983-07-06 | Mitsui Toatsu Chemicals | Process for purifying sugar fatty acid ester |
JPS6025183B2 (ja) | 1979-06-07 | 1985-06-17 | 株式会社資生堂 | 多価アルコ−ル中油型乳化組成物 |
EP0050887B1 (en) * | 1980-10-16 | 1984-05-02 | Unilever N.V. | Stable liquid detergent suspensions |
JPS5916534A (ja) | 1982-07-19 | 1984-01-27 | Lion Corp | 非イオン性界面活性剤系ベシクル分散液 |
JPS59106423A (ja) | 1982-12-08 | 1984-06-20 | Hiroshi Kiwada | リポソ−ム |
JPS60258195A (ja) | 1984-06-05 | 1985-12-20 | Ss Pharmaceut Co Ltd | α.α―トレハロース脂肪酸ジエステル誘導体 |
US4880635B1 (en) | 1984-08-08 | 1996-07-02 | Liposome Company | Dehydrated liposomes |
DK175432B1 (da) * | 1984-10-30 | 2004-10-18 | Otsuka Pharma Co Ltd | Middel til forögelse af anticancervirkningen af anticancerforbindelser |
EP0208764A4 (en) | 1985-01-11 | 1987-10-08 | Univ California | PRESERVATION PROCEDURE FOR LIPOSOME. |
JPS61207324A (ja) * | 1985-03-11 | 1986-09-13 | Agency Of Ind Science & Technol | リポソ−ム |
JPS61289038A (ja) | 1985-06-14 | 1986-12-19 | Ss Pharmaceut Co Ltd | 抗癌剤 |
JPS63122620A (ja) * | 1986-11-12 | 1988-05-26 | Sanraku Inc | ポリ乳酸マイクロスフエア及びその製造方法 |
JPS6475421A (en) | 1987-09-17 | 1989-03-22 | Sawai Seiyaku Kk | Freeze-dried preparation of liposome containing alpha,alpha-trehalose trimycolic acid ester |
JPH0278623A (ja) * | 1988-09-14 | 1990-03-19 | Sawai Seiyaku Kk | インターフェロン誘起剤 |
JPH03157349A (ja) | 1989-11-14 | 1991-07-05 | Lion Corp | 乳化組成物 |
FR2668930B1 (fr) | 1990-11-09 | 1995-02-17 | Oreal | Composition cosmetique, pharmaceutique ou alimentaire comportant une dispersion aqueuse de vesicules lipidiques. |
US5168893A (en) * | 1991-11-08 | 1992-12-08 | Ingersoll-Rand Company | Block and bleed valve |
ZA931613B (en) * | 1992-04-15 | 1993-11-15 | Curtis Helene Ind Inc | Conditioning shampoo composition and method of preparing and using the same |
JPH06291236A (ja) | 1993-03-30 | 1994-10-18 | Hitachi Cable Ltd | 半導体装置 |
US5744155A (en) * | 1993-08-13 | 1998-04-28 | Friedman; Doron | Bioadhesive emulsion preparations for enhanced drug delivery |
-
1993
- 1993-10-07 JP JP27765393A patent/JP3187622B2/ja not_active Expired - Fee Related
-
1994
- 1994-05-31 DE DE69431163T patent/DE69431163T2/de not_active Expired - Lifetime
- 1994-05-31 EP EP95904334A patent/EP0729781B1/en not_active Expired - Lifetime
- 1994-05-31 WO PCT/JP1994/000874 patent/WO1995009692A1/ja active IP Right Grant
- 1994-05-31 US US08/628,674 patent/US6497898B1/en not_active Expired - Lifetime
-
2002
- 2002-09-18 US US10/246,431 patent/US20040022819A1/en not_active Abandoned
-
2007
- 2007-03-12 US US11/716,599 patent/US20070292462A1/en not_active Abandoned
- 2007-03-12 US US11/716,870 patent/US20070160556A1/en not_active Abandoned
-
2008
- 2008-12-01 US US12/325,646 patent/US20090098172A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05137994A (ja) * | 1991-11-19 | 1993-06-01 | Kanebo Ltd | 界面活性剤 |
JPH05168893A (ja) * | 1991-12-19 | 1993-07-02 | Kanebo Ltd | 界面活性剤 |
JPH0616688A (ja) * | 1992-06-30 | 1994-01-25 | Nippon Oil & Fats Co Ltd | 脂肪酸糖エステル |
Non-Patent Citations (1)
Title |
---|
SUPERVISED BY TAKAO KARIGOME, "Special Functional Surfactant", 31 October 1988, CMC, P. 32-34. * |
Also Published As
Publication number | Publication date |
---|---|
US20070292462A1 (en) | 2007-12-20 |
US20070160556A1 (en) | 2007-07-12 |
US20040022819A1 (en) | 2004-02-05 |
US20090098172A1 (en) | 2009-04-16 |
DE69431163D1 (de) | 2002-09-12 |
DE69431163T2 (de) | 2002-12-12 |
JP3187622B2 (ja) | 2001-07-11 |
JPH07108166A (ja) | 1995-04-25 |
EP0729781A4 (en) | 1998-02-04 |
EP0729781A1 (en) | 1996-09-04 |
US6497898B1 (en) | 2002-12-24 |
EP0729781B1 (en) | 2002-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070160556A1 (en) | Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant | |
EP2088986B1 (en) | Skin external preparation in the form of water-in-oil emulsion comprising ceramide | |
JP3355458B2 (ja) | 脂質小胞の水性分散液を含む化粧品的、薬学的 または食料品化合物 | |
JP2001500886A (ja) | 親油性領域中に比較的長い鎖を有する分子が挿入されるか又は疎水性の相互作用によりこのような分子と結合されている、脂質二重膜を有する構造物 | |
JP2007332088A (ja) | ベシクル系に好適な皮膚外用剤 | |
JPH0441125B2 (ja) | ||
JP2003300859A (ja) | 皮膚外用剤 | |
JP2000511945A (ja) | 安定化白化組成物及びその製造方法 | |
JP2005179313A (ja) | 皮膚化粧料用基剤の製造方法および皮膚化粧料 | |
JP5198899B2 (ja) | 細胞賦活剤及び老化防止用皮膚外用剤 | |
ES2364595T3 (es) | Preparación externa para la piel en forma de emulsión de agua en aceite que comprende ceramida. | |
JP2000247987A (ja) | 高度水素添加レシチン | |
EP0375082A2 (en) | Cosmetic composition | |
JP5420848B2 (ja) | 美白剤及び美白用皮膚外用剤 | |
JP3822959B2 (ja) | 老化防止用皮膚外用剤 | |
JP5641665B2 (ja) | 皮膚外用剤及びその製造方法 | |
JPH10231229A (ja) | 化粧料 | |
JPH09104614A (ja) | 皮膚化粧料 | |
JP2009203192A (ja) | インボルクリン産生促進剤、及び肌荒れ防止又は改善用皮膚外用剤 | |
JP2005089390A (ja) | 化粧料 | |
JPH1180016A (ja) | 老化防止用皮膚外用剤 | |
JPH08310938A (ja) | 皮膚外用剤 | |
JPH0686374B2 (ja) | 脂溶性物質含有水性液 | |
JP2002145758A (ja) | 化粧料 | |
JPH10182331A (ja) | 化粧料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) |
Free format text: EUROPEAN PATENT(AT,BE,DE,DK,FR,GB,IE,IT,LU,MC,NL,PT,SE) |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1995904334 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08628674 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1995904334 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1995904334 Country of ref document: EP |